Publications
5491 Results
- Journal / Conference
- Journal of the National Comprehensive Cancer Network Nov;21(11):1172-1180.e3
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37935109
- PMC
- PMC10976748
- Study Number(s)
- S0221
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221
- Journal / Conference
- Haematologica Aug 3; doi: 10.3324/haematol.2023.283520 Online ahead of print
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID:37534515
- PMC
- PMC10081409
- Study Number(s)
- S0106
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
- Journal / Conference
- JCO Oncology Practice Dec;19(12):1160-1167
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37788414
- PMC
- PMC10732502
- Study Number(s)
- S1415CD
Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing
- Journal / Conference
- Supportive Care in Cancer Sep 28;31(10):598
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37770704
- PMC
- PMC11060514
- Study Number(s)
- S1415CD
Impact of Treatment Experience on Patient Knowledge of Colony Stimulating Factors Among Patients Receiving Cancer Chemotherapy: Evidence from S1415CD, A Large Pragmatic Trial
- Journal / Conference
- SABCS (San Antonio Breast Cancer Symposium, December 5-9, San Antonio, TX), Poster Spotlight Discussion, PS04-08
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1105
Sociodemographic risk factors and prediction of aromatase inhibitor non-adherence in women with breast cancer enrolled in SWOG S1105
- Journal / Conference
- ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
- Year
- 2023
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1318
Long-term Follow for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
- Journal / Conference
- ASH Annual Meeting (Dec 9-12,2023, San Diego, CA), poster
- Year
- 2023
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Minimal residual disease (MRD) status predicts outcomes in patients with follicular lymphoma (FL) treated with chemo-immunotherapy on SWOG S0016 study
- Journal / Conference
- ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
- Year
- 2023
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1203
Class III obesity is associated with worse overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203
- Journal / Conference
- SUO (Society of Urologic Oncology) (Nov 28-Dec 1, Washington, DC), TIPS, poster
- Year
- 2023
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1931
SWOG S1931 (PROBE): Phase III randomized trial of Immune checkpoint inhibitor (ICI) combination regimen with or without Cytoreductive Nephrectomy (CN) in Advanced Renal Cancer [NCT04510597]
- Journal / Conference
- ASH Annual Meeting (Dec 9-12, 2023, San Diego), oral
- Year
- 2023
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826